140 related articles for article (PubMed ID: 20647545)
1. Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
Idris AI; Krishnan M; Simic P; Landao-Bassonga E; Mollat P; Vukicevic S; Ralston SH
FASEB J; 2010 Nov; 24(11):4545-55. PubMed ID: 20647545
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo.
Idris AI; Libouban H; Nyangoga H; Landao-Bassonga E; Chappard D; Ralston SH
Mol Cancer Ther; 2009 Aug; 8(8):2339-47. PubMed ID: 19671767
[TBL] [Abstract][Full Text] [Related]
3. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
4. Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.
Van 't Hof RJ; Idris AI; Ridge SA; Dunford J; Greig IR; Ralston SH
J Bone Miner Res; 2004 Oct; 19(10):1651-60. PubMed ID: 15355560
[TBL] [Abstract][Full Text] [Related]
5. Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
Sun P; Yang Q; Wang Y; Peng J; Zhao K; Jia Y; Zhang T; Lu X; Han W; Qian Y
Drug Des Devel Ther; 2020; 14():4189-4203. PubMed ID: 33116407
[TBL] [Abstract][Full Text] [Related]
6. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
7. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
8. Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo.
Lee J; Noh AL; Zheng T; Kang JH; Yim M
Exp Cell Res; 2015 Dec; 339(2):380-8. PubMed ID: 26450448
[TBL] [Abstract][Full Text] [Related]
9. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).
Armour KJ; van 't Hof RJ; Armour KE; Torbergsen AC; Del Soldato P; Ralston SH
Arthritis Rheum; 2001 Sep; 44(9):2185-92. PubMed ID: 11592384
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
12. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
[TBL] [Abstract][Full Text] [Related]
13. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
[TBL] [Abstract][Full Text] [Related]
14. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
15. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
16. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
17. Mycoepoxydiene suppresses RANKL-induced osteoclast differentiation and reduces ovariectomy-induced bone loss in mice.
Zhu J; Chen Q; Xia X; Mo P; Shen Y; Yu C
Appl Microbiol Biotechnol; 2013 Jan; 97(2):767-74. PubMed ID: 22678021
[TBL] [Abstract][Full Text] [Related]
18. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
19. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.
Mei L; Sang W; Chen Z; Zheng L; Jin K; Lou C; Huang W; He D
J Cell Physiol; 2018 Dec; 233(12):9724-9738. PubMed ID: 30059597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
